Pre-clinical animal model and cell evaluation of candidate therapies for human NUBPL disease.

Awardee: Marni Falk

Institution: Children's Hospital of Philadelphia and University of Pennsylvania

Award Amount: $61,134

Previous
Previous

Development of novel human stem cell models of Beta-Propeller Protein- Associated Neurodegeneration (BPAN) for disease modelling and drug screening

Next
Next

Genetic Mechanisms in Neuroendocrine cell Hyperplasia of Infancy (NEHI)